Clinical Trial Update: Imatinib in KIT-negative Systemic Mastocytosis [Phase 4]

View source ↗

Summary

The Phase 4 clinical trial evaluating imatinib for KIT-negative systemic mastocytosis has completed. The snippet provides basic trial status but does not includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Mastocytosis

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Hospital Virgen de la Salud | Conditions: Systemic Mastocytosis | Phase 4 | Status: COMPLETED